Micro Cap Ideas

[gfp927z]

>>> SenesTech Announces Pricing of $4.1 Million Public Offering of Common Stock


PR Newswire

July 11, 2019


https://finance.yahoo.com/news/senestech-announces-pricing-4-1-014200577.html


FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the pricing of its previously announced public offering of 3,037,038 shares of its common stock at a price to the public of $1.35 per share. SenesTech expects to receive aggregate gross proceeds of approximately $4.1 million from the offering. The offering is expected to close on or about July 16, 2019, subject to customary closing conditions.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

SenesTech intends to use the net proceeds from the offering for working capital and other general corporate purposes.

The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018. A preliminary prospectus supplement describing the terms of the offering was filed with the SEC on July 11, 2019, and is available on the SEC's website at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained, when available, from H.C. Wainwright & Co., LLC, 430 Park Avenue 3rd Floor, New York, NY 10022, or by calling [phone] or by emailing [e-mail] or at the SEC's website at http://www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.

About SenesTech

SenesTech has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. For more information visit the SenesTech website at www.senestech.com.

<<<